Clinical Trial Update: Biodentine Vital Pulpotomy in Immature Molars [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on BiodentineVital Pulpotomy in immature molars completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Pulp Exposure Disorders
• Pulp Exposure in Immature Molars

Drugs mentioned

• Biodentine Vital Pulpotomy (Biodentine) (sodium silicate-based dentin substitute? (Note: Biodentine is tricalcium silicate-based dentin substitute))

Snippet

Sponsor: Cairo University | Conditions: Pulp Exposure, Dental | Phase 4 | Status: COMPLETED